Hongbing Ma

570 total citations
20 papers, 458 citations indexed

About

Hongbing Ma is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Hongbing Ma has authored 20 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Hongbing Ma's work include RNA modifications and cancer (4 papers), Immunotherapy and Immune Responses (4 papers) and Garlic and Onion Studies (3 papers). Hongbing Ma is often cited by papers focused on RNA modifications and cancer (4 papers), Immunotherapy and Immune Responses (4 papers) and Garlic and Onion Studies (3 papers). Hongbing Ma collaborates with scholars based in China and Finland. Hongbing Ma's co-authors include Yong Li, Dong Chen, Pei Wang, Dong Chen, Xi-Jing Wang, Xiaoran Yin, Kun Xu, Shuqun Zhang, Dong Liu and Cheng Feng and has published in prestigious journals such as International Journal of Molecular Sciences, RSC Advances and World Journal of Gastroenterology.

In The Last Decade

Hongbing Ma

18 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongbing Ma China 11 328 224 72 51 50 20 458
Livio Muccillo Italy 11 261 0.8× 147 0.7× 46 0.6× 57 1.1× 74 1.5× 16 424
Chenglin Li China 13 379 1.2× 162 0.7× 59 0.8× 44 0.9× 62 1.2× 29 544
Eun-Yeong Kim South Korea 13 239 0.7× 155 0.7× 33 0.5× 70 1.4× 48 1.0× 24 448
Fuquan Chen China 11 428 1.3× 223 1.0× 55 0.8× 45 0.9× 55 1.1× 21 565
Wenjie Yang China 14 450 1.4× 140 0.6× 190 2.6× 61 1.2× 54 1.1× 39 655
Chen Zou China 11 262 0.8× 185 0.8× 40 0.6× 28 0.5× 26 0.5× 25 392
Yanxia Li China 13 291 0.9× 106 0.5× 43 0.6× 70 1.4× 71 1.4× 25 463
Jianyang Hu China 11 354 1.1× 100 0.4× 40 0.6× 51 1.0× 92 1.8× 16 511
Yiqun Yao China 11 299 0.9× 96 0.4× 35 0.5× 32 0.6× 59 1.2× 25 456

Countries citing papers authored by Hongbing Ma

Since Specialization
Citations

This map shows the geographic impact of Hongbing Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbing Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbing Ma more than expected).

Fields of papers citing papers by Hongbing Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbing Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbing Ma. The network helps show where Hongbing Ma may publish in the future.

Co-authorship network of co-authors of Hongbing Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Hongbing Ma. A scholar is included among the top collaborators of Hongbing Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbing Ma. Hongbing Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Xiaojing, Ping Tang, Hongbing Ma, et al.. (2025). Vanillic acid protects against ulcerative colitis by modulating oxidative stress, inflammatory response, macrophage polarization and AMPK signaling pathways. International Immunopharmacology. 168(Pt 2). 115928–115928.
3.
Zhang, Ruijuan, et al.. (2024). CD39 inhibitor (POM-1) enhances radiosensitivity of esophageal squamous cell carcinoma (ESCC) cells by promoting apoptosis through the Bax/Bcl-2/Caspase 9/Caspase 3 pathway. International Immunopharmacology. 142(Pt B). 113242–113242. 4 indexed citations
4.
Shi, Xiaobo, Xiaoxiao Liu, Hao Yu, et al.. (2022). miR-4443 promotes radiation resistance of esophageal squamous cell carcinoma via targeting PTPRJ. Journal of Translational Medicine. 20(1). 626–626. 10 indexed citations
5.
Wu, Yibo, Yihui Zhu, Hongbing Ma, et al.. (2022). Investigation of eight-arm tapered star copolymers prepared by anionic copolymerization and coupling reaction. Polymer Chemistry. 13(26). 3938–3948. 4 indexed citations
6.
Wang, Huaqing, Yong Zeng, Minghui Zhang, et al.. (2019). CD56brightCD16− natural killer cells are shifted toward an IFN-γ-promoting phenotype with reduced regulatory capacity in osteoarthritis. Human Immunology. 80(10). 871–877. 14 indexed citations
7.
Ma, Hongbing, Shuyu Zheng, Xiaozhi Zhang, et al.. (2019). High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy. Cell Death and Disease. 10(2). 136–136. 32 indexed citations
8.
Wang, Pei, Dong Chen, Hongbing Ma, & Yong Li. (2017). LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis. OncoTargets and Therapy. Volume 10. 5137–5149. 101 indexed citations
10.
Chen, Dong, et al.. (2017). Long non-coding RNA MEG3 regulates proliferation and apoptosis in non-small cell lung cancer via the miR-205-5p/LRP1 pathway. RSC Advances. 7(78). 49710–49719. 6 indexed citations
11.
Ma, Hongbing, et al.. (2016). Effects of lung cancer cell-associated B7-H1 on T-cell proliferation in vitro and in vivo. Brazilian Journal of Medical and Biological Research. 49(7). 3 indexed citations
12.
Jin, Yingying, Qingjuan Chen, Wei Yang, et al.. (2016). Upregulation of microRNA-98 increases radiosensitivity in esophageal squamous cell carcinoma. Journal of Radiation Research. 57(5). 468–476. 19 indexed citations
13.
Yin, Xiaoran, Rong Zhang, Cheng Feng, et al.. (2014). Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK pathways in human esophageal squamous cell carcinoma. Oncology Reports. 32(4). 1748–1756. 46 indexed citations
14.
Ma, Hongbing. (2014). Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells. World Journal of Gastroenterology. 20(1). 193–193. 43 indexed citations
15.
Yin, Xiaoran, Jun Zhang, Xiaoning Li, et al.. (2014). DADS Suppresses Human Esophageal Xenograft Tumors through RAF/MEK/ERK and Mitochondria-Dependent Pathways. International Journal of Molecular Sciences. 15(7). 12422–12441. 32 indexed citations
16.
Wang, Baofeng, Zhijun Dai, Xi-Jing Wang, et al.. (2013). Saikosaponin-d increases the radiosensitivity of smmc-7721 hepatocellular carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the cell cycle. BMC Complementary and Alternative Medicine. 13(1). 263–263. 37 indexed citations
17.
Qi, Chunjian, Keqing Qian, Yongling Ning, et al.. (2009). Ligation or cross-linking of CD40 has different effects on AGS gastric cancer cells. Cellular Immunology. 259(2). 135–140. 6 indexed citations
18.
Qi, Chunjian, Lu Zheng, Hongbing Ma, et al.. (2009). A novel mutation in CD40 and its functional characterization. Human Mutation. 30(6). 985–994. 4 indexed citations
19.
Ma, Hongbing. (2007). Construction of targeted plasmid vector pcDNA3.1-Egr.1p-p16 and its expression in pancreatic cancer JF305 cells induced by radiationin vitro. World Journal of Gastroenterology. 13(31). 4214–4214. 3 indexed citations
20.
Mao, Yixiang, Yongjing Chen, Yan Ge, et al.. (2006). Recombinant human B7-H4 expressed in Escherichia coli inhibits T lymphocyte proliferation and IL-2 secretion in vitro1. Acta Pharmacologica Sinica. 27(6). 741–746. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026